Page 341 - Clinical Immunology_ Principles and Practice ( PDFDrive )
P. 341

CHaPtEr 22  Phagocyte Deficiencies              321


           affecting isoform A have only SCN, as opposed to patients with
           mutations affecting both isoforms (A and B), who develop   Primary Autoimmune Neutropenia
           neurological problems in addition to SCN. 8            Primary AIN is seen in infancy unassociated with other systemic
             Dominant zinc finger mutations disabling transcriptional   immune-mediated disorders and is the most common form of
           repressor activity of the growth factor independent 1 (GFI1) gene   neutropenia, equally affecting boys and girls at around 1/100
                                                    4
                                                                     12
           have been described in a few patients with SCN.   GFI1 is a   000.  The average age at diagnosis is 8 months. The majority
           transcriptional repressor prooncogene controlling normal   present with mild skin and upper respiratory tract infections;
           hematopoietic cell differentiation and also regulates ELANE as   some patients remain asymptomatic despite low neutrophil
           well as several of the CAAT enhancer binding proteins (C/EBP).   counts. The majority of patients have a neutrophil count greater
           Mutations in  GFI1 are also associated with aberrations in   than 500 cells/µL at the time of diagnosis, but the ANCs may
           lymphoid and myeloid cells, leading to a circulating population   transiently increase two- to threefold during severe infection.
           of immature myeloid cells. Gfi1 knock-out mice have impaired   Bone marrow shows normal to increased cellularity. Myeloid
           T-helper type 2 (Th2) regulation and B-cell, Th17, and dendritic-  precursors typically reach the myelocyte/metamyelocyte stage.
           cell (DC) differentiation.                             Phagocytosed granulocytes in bone marrow may indicate removal
             Mutations in the  glucose-6-phosphatase catalytic subunit 3   of sensitized granulocytes there. Granulocyte-specific antibodies
           (G6PC3) gene complex cause another form of SCN along with   are detected by direct granulocyte immunofluorescence testing
                                        9
           developmental and somatic problems.  G6PC3 encodes glucose-6-  (D-GIFT), the vast majority of which are immunoglobulin G
           phosphatase-β, which hydrolyzes glucose-6-phosphate (G6P) in   (IgG) against glycoproteins of the granulocyte membrane des-
           the final step of gluconeogenesis and glycogenolysis. It is coupled   ignated neutrophil antigens (NAs). NAs are located on IgG
           to a glucose transporter (G6PT) that facilitates G6P transport   receptor IIA or IIIB (FcγRIIa and FcγRIIIb).
           from the cytoplasm to the endoplasmic reticulum. Mutations in   AIN is generally self-limiting. Disappearance of the antibodies
           the G6PT gene lead to glycogen storage disease type Ib, which has   from the circulation precedes normalization of neutrophil counts.
           variable neutropenia and infections and other complications, such   Prophylactic antibiotic treatment should be reserved for those
           as liver adenomas, growth retardation, osteoporosis, polycystic   with recurrent infections. Alternative treatment strategies for
           ovaries, and inflammatory bowel disease (IBD). Children with   severe infections and in the setting of emergency surgical interven-
           these complications have increased susceptibility to bacterial   tions include high-dose intravenous immunoglobulin (IVIG),
           infections and cardiovascular abnormalities, including prominent   corticosteroids, and G-CSF, with the latter being the most effective
           ectatic superficial veins.                             at increasing the ANC.

           Shwachman-Bodian-Diamond Syndrome                      Secondary Autoimmune Neutropenia
           Shwachman-Bodian-Diamond syndrome  (SBDS) was first    Secondary AIN can be seen at any age and has a more variable
           described in 1964 as a disorder with pancreatic exocrine insuf-  clinical course. Hepatitis, systemic lupus erythematosus (SLE),
           ficiency and bone marrow dysfunction. Currently, it is recognized   or Hodgkin disease may underlie it and cause other autoimmune
           as the second most common cause of inherited exocrine pancreatic   problems as well. These antineutrophil antibodies (ANAs) have
           insufficiency after cystic fibrosis. It is autosomal recessive (located   pan-FcγRIII specificity. CD18/CD11b antibodies have been
                                                    10
           at 7q11) with an estimated incidence of 0.5–1/100 000.  The SDBS   detected in  a subset of patients with  secondary  AIN.  This
           protein belongs to a highly conserved protein family involved in   neutropenia responds poorly to most therapies.
           RNA metabolism. Mutations cause defects in the development
           of the exocrine pancreas, hematopoiesis, and chondrogenesis.   Alloimmune Neonatal Neutropenia
           Recurring  mutations  result  from  gene  conversion  caused  by   First described by Lalezari in 1966, alloimmune neonatal neu-
           recombination with a pseudogene in 89% of unrelated patients;   tropenia (ANN) is caused by the transplacental transfer of
           60% carry two converted alleles. (Pseudogene conversion is also   maternal antibodies against the fetal neutrophil antigens NA1,
           the cause of the majority of cases of p47 phox -deficient chronic   NA2, and NB1, leading to immune destruction of neonatal
                                                                           13
           granulomatous disease [CGD].)                          neutrophils.  These complement-activating antineutrophil IgG
             Patients present with recurrent infections, failure to thrive,   antibodies can be detected in about 1/500 live births. Antibody
           hematopoietic dysfunction, metaphyseal dysostosis, growth   coated neutrophils in ANN are phagocytosed by the reticuloen-
           retardation, and fatty replacement of the pancreas. Most patients   dothelial system and removed from circulation, leaving the
           have mild neutropenia, and a few have neutrophil counts below   neutropenic neonate at risk for infections. Omphalitis, cellulitis,
                                                     11
           500 cells/µL, which can be intermittent or chronic.  Anemia   and pneumonia typically occur within the first 2 weeks of life
           and thrombocytopenia are associated with neutropenia. Congenital   in association with neutropenia. Diagnosis can be made by
           aplastic anemia is an unusual presentation. Upper and lower   detection of neutrophil-specific alloantibodies in the maternal
           respiratory tract pyogenic infections are common and related   serum. ANN responds to G-CSF or high-dose IVIG, but most
           to neutropenia. Short ribs with broadened anterior ends are   patients improve without specific treatment in a few weeks to
           common radiological findings, along with metaphyseal dyschon-  6 months with waning of maternal antibody.
           droplasia  of  the  femoral  head.  The  diagnosis  is  suggested  by
           neutropenia, radiological findings, and abnormal pancreatic   DEFECTS OF LEUKOCYTE ADHESION
           exocrine function. It is confirmed by gene sequencing.
                                                                  Migration of circulating leukocytes from the bloodstream into
           Autoimmune Neutropenia                                 tissues depends on complex bidirectional interactions between
           Autoimmune neutropenia (AIN) is caused by peripheral   leukocytes and endothelial cells (Chapter 11). The initial steps
           destruction of neutrophils as a result of granulocyte-specific   involve the activation of circulating leukocytes by signal molecules
           autoantibodies. 12                                     released from inflamed tissues or from the bacteria themselves.
   336   337   338   339   340   341   342   343   344   345   346